Hegenbart U - Search Results

1

Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis.

Granzow M, Hegenbart U, Hinderhofer K, Hose D, Seckinger A, Bochtler T, Hemminki K, Goldschmidt H, Schönland SO, Jauch A. Granzow M, et al. Among authors: hegenbart u. Haematologica. 2017 Jul;102(7):1281-1290. doi: 10.3324/haematol.2016.160721. Epub 2017 Mar 24. Haematologica. 2017. PMID: 28341732 Free PMC article.

2

[Gastrointestinal amyloidosis in IgG-kappa-light-chain plasmocytoma].

Hegenbart U, Goldschmidt H. Hegenbart U, et al. Dtsch Med Wochenschr. 1995 Aug 25;120(34-35):1187. Dtsch Med Wochenschr. 1995. PMID: 7656858 German. No abstract available.

3

[Paroxysmal nocturnal hemoglobinuria. Differentiation from other acquired hemolytic anemias and confirming the diagnosis].

Hegenbart U, Goldschmidt H. Hegenbart U, et al. Z Arztl Fortbild (Jena). 1994 Jan;88(1):59-62. Z Arztl Fortbild (Jena). 1994. PMID: 8154143 German. No abstract available.

4

Mobilization of peripheral blood progenitor cells with high-dose cyclophosphamide (4 or 7 g/m2) and granulocyte colony-stimulating factor in patients with multiple myeloma.

Goldschmidt H, Hegenbart U, Haas R, Hunstein W. Goldschmidt H, et al. Among authors: hegenbart u. Bone Marrow Transplant. 1996 May;17(5):691-7. Bone Marrow Transplant. 1996. PMID: 8733683 Clinical Trial.

5

Sequential high-dose treatment with peripheral blood progenitor cell transplantation in patients with multiple myeloma.

Goldschmidt H, Hegenbart U, Moos M, Eugenhart R, Wannenmacher M, Haas R, Hunstein W. Goldschmidt H, et al. Among authors: hegenbart u. Stem Cells. 1995 Dec;13 Suppl 3:36-41. doi: 10.1002/stem.5530130707. Stem Cells. 1995. PMID: 8747987 Clinical Trial.

6

High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma.

Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Engenhart R, Wannenmacher M, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Ann Oncol. 1997 Mar;8(3):243-6. doi: 10.1023/a:1008252227512. Ann Oncol. 1997. PMID: 9137792 Free article. Clinical Trial.

7

[Malignant lymphoma. Pathology, diagnosis, therapy].

Goldschmidt H, Wallmeier M, Hegenbart U, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Radiologe. 1997 Jan;37(1):1-9. doi: 10.1007/s001170050171. Radiologe. 1997. PMID: 9157471 Review. German.

8

Peripheral blood progenitor cell transplantation in multiple myeloma following high-dose melphalan-based therapy.

Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Engenhart R, Wannenmacher M, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Recent Results Cancer Res. 1998;144:27-35. doi: 10.1007/978-3-642-46836-0_4. Recent Results Cancer Res. 1998. PMID: 9304704

9

Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma.

Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Br J Haematol. 1997 Sep;98(3):736-44. doi: 10.1046/j.1365-2141.1997.2783095.x. Br J Haematol. 1997. PMID: 9332333 Free article.

10

High-dose chemotherapy in multiple myeloma.

Goldschmidt H, Hegenbart U, Wallmeier M, Moos M, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Leukemia. 1997 Dec;11 Suppl 5:S27-31. Leukemia. 1997. PMID: 9436935 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters